A control model to evaluate pharmacotherapy for allergic rhinitis in children

JAMA Pediatrics

Volumn 167, Issue 4, 2013, Pages 380-386

  Rachelefsky, Gary ^a   Farrar, Judith Rosen ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Life Sciences Press   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; MONTELUKAST; OLOPATADINE; PLACEBO; STEROID; TRIAMCINOLONE ACETONIDE;

ALLERGIC RHINITIS; APNEA HYPOPNEA INDEX; ASTHMA; BRONCHUS HYPERREACTIVITY; CHILD; COMORBIDITY; CONTROLLED CLINICAL TRIAL (TOPIC); DISEASE CONTROL; DRUG EFFICACY; EMBASE; EMOTION; FATIGUE; FORCED EXPIRATORY FLOW; GROUPS BY AGE; HAY FEVER; HEALTH CARE UTILIZATION; HUMAN; LEARNING; LUNG FUNCTION; MEDLINE; MEMORY; MODEL; NOSE OBSTRUCTION; OUTCOME ASSESSMENT; PERENNIAL RHINITIS; POLYSOMNOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECALL; REVIEW; RHINORRHEA; RISK ASSESSMENT; RISK FACTOR; SLEEP; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP QUALITY; SNEEZING; SYMPTOM; SYSTEMATIC REVIEW; VITAL CAPACITY;

BUDESONIDE; CHILD; COMORBIDITY; EARLY DIAGNOSIS; GLUCOCORTICOIDS; HEALTH STATUS INDICATORS; HUMANS; QUALITY OF LIFE; QUESTIONNAIRES; RHINITIS, ALLERGIC, PERENNIAL; SLEEP APNEA, OBSTRUCTIVE;

EID: 84876034262     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2013.623     Document Type: Review

References (62)

1. Rachelefsky GS. National guidelines needed to manage rhinitis and prevent complications. Ann Allergy Asthma Immunol. 1999;82(3):296-305. (Pubitemid 29141092)
2. Simon RA. The allergy-asthma connection. Allergy Asthma Proc. 2002;23(4):219-222.
3. Rachelefsky G. Inhaled corticosteroids and asthma control in children: assessing impairment and risk. Pediatrics. 2009;123(1):353-366.
4. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health; 2007. www.nhlbi.nih.gov/guidelines/asthma. Accessed September 14, 2011.
5. Marple BF, Fornadley JA, Patel AA, et al; American Academy of Otolaryngic Allergy Working Group on Allergic Rhinitis. Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction. Otolaryngol Head Neck Surg. 2007;136(6) (suppl):S107-S124. (Pubitemid 46778874)
6. Benninger M, Farrar JR, Blaiss M, et al. Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class. Ann Allergy Asthma Immunol. 2010;104(1):13-29.
7. Wright AL, Holberg CJ, Martinez FD, Halonen M, Morgan W, Taussig LM. Epidemiology of physician-diagnosed allergic rhinitis in childhood. Pediatrics. 1994;94(6, pt 1):895-901. (Pubitemid 24359195)
8. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001;108(1) (suppl):S2-S8.
9. Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc. 2007;28(1):3-9.
10. Wallace DV, Dykewicz MS, Bernstein DI, et al; Joint Task Force on Practice; American Academy of Allergy; Asthma & Immunology; American College of Allergy; Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(2) (suppl):S1-S84. (Pubitemid 352033573)
11. Meltzer EO, Blaiss MS, Derebery MJ, et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. J Allergy Clin Immunol. 2009;124(3) (suppl):S43-S70.
12. Westman M, Stjärne P, Asarnoj A, et al. Natural course and comorbidities of allergic and nonallergic rhinitis in children. J Allergy Clin Immunol. 2012;129(2):403-408.
13. Craig TJ, McCann JL, Gurevich F, Davies MJ. The correlation between allergic rhinitis and sleep disturbance. J Allergy Clin Immunol. 2004;114:S139-S145. (Pubitemid 39440925)
14. Engel-Yeger B, Engel A, Kessel A. Differences in leisure activities between children with allergic rhinitis and healthy peers. Int J Pediatr Otorhinolaryngol. 2010;74(12):1415-1418.
15. Bender BG, Milgrom H. Comparison of the effects of fluticasone propionate aqueous nasal spray and loratadine on daytime alertness and performance in children with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2004;92(3):344-349. (Pubitemid 38380792)
16. Mansfield LE, Diaz G, Posey CR, Flores-Neder J. Sleep disordered breathing and daytime quality of life in children with allergic rhinitis during treatment with intranasal budesonide. Ann Allergy Asthma Immunol. 2004;92(2):240-244. (Pubitemid 38233663)
17. Chen ST, Lu KH, Sun HL, Chang WT, Lue KH, Chou MC. Randomized placebocontrolled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr. Pediatr Allergy Immunol. 2006;17(1):49-54.
18. de Blic J, Wahn U, Billard E, Alt R, Pujazon MC. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. Pediatr Allergy Immunol. 2005;16(3):267-275. (Pubitemid 40638057)
19. Lai DS, Lue KH, Hsieh JC, Lin KL, Lee HS. The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2002;89(6):589-598.
20. Lee CF, Sun HL, Lu KH, Ku MS, Lue KH. The comparison of cetirizine, levocetirizine and placebo for the treatment of childhood perennial allergic rhinitis. Pediatr Allergy Immunol. 2009;20(5):493-499.
21. Potter PC; Paediatric Levocetirizine Study Group. Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial. Ann Allergy Asthma Immunol. 2005;95(2):175-180. (Pubitemid 41170179)
22. Berger WE, Ratner PH, Casale TB, Meltzer EO, Wall GM. Safety and efficacy of olopatadine hydrochloride nasal spray 0.6% in pediatric subjects with allergic rhinitis. Allergy Asthma Proc. 2009;30(6):612-623.
23. Meltzer EO, Blaiss M, Fairchild CJ. Comprehensive report of olopatadine 0.6% nasal spray as treatment for children with seasonal allergic rhinitis. Allergy Asthma Proc. 2011;32(3):213-220.
24. Lack G. Pediatric allergic rhinitis and comorbid disorders. J Allergy Clin Immunol. 2001;108(1) (suppl):S9-S15. (Pubitemid 32678752)
25. Spector SL. Overview of comorbid associations of allergic rhinitis. J Allergy Clin Immunol. 1997;99(2) (suppl):S773-S780. (Pubitemid 27091594)
26. Fokkens WJ, Cserháti E, dos Santos JM, et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours. Ann Allergy Asthma Immunol. 2002;89(3):279-284. (Pubitemid 36188027)
27. Fokkens WJ, Scadding GK. Perennial rhinitis in the under 4s: a difficult problem to treat safely and effectively? a comparison of intranasal fluticasone propionate and ketotifen in the treatment of 2-4-year-old children with perennial rhinitis. Pediatr Allergy Immunol. 2004;15(3):261-266. (Pubitemid 38937571)
28. Jordana G, Dolovich J, Briscoe MP, et al. Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis. J Allergy Clin Immunol. 1996;97(2):588-595. (Pubitemid 26062756)
29. Ciprandi G, Tosca M, Passalacqua G, Canonica GW. Long-term cetirizine treatment reduces allergic symptoms and drug prescriptions in children with mite allergy. Ann Allergy Asthma Immunol. 2001;87(3):222-226. (Pubitemid 32879895)
30. Kessel A, Halloun H, Bamberger E, Kugelman A, Toubi E. Abnormal spirometry in children with persistent allergic rhinitis due to mite sensitization: the benefit of nasal corticosteroids. Pediatr Allergy Immunol. 2008;19(1):61-66.
31. Orhan F, Sekerel BE, Adalioglu G, Pinar M, Tuncer A. Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2004;92(4):438-445. (Pubitemid 39077586)
32. Oztürk F, Türktaş I, Asal K, Ileri F, Münevver Pinar N. Effect of intranasal triamcinolone acetonide on bronchial hyper-responsiveness in children with seasonal allergic rhinitis and comparison of perceptional nasal obstruction with acoustic rhinometric assessment. Int J Pediatr Otorhinolaryngol. 2004;68(8):1007-1015.
33. Guyatt GH, Oxman AD, Vist GE, et al; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926. (Pubitemid 351632017)
34. Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ. Interpretation of rhinoconjunctivitis quality of life questionnaire data. J Allergy Clin Immunol. 1996;98(4):843-845. (Pubitemid 26357253)
35. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol. 1994;93(2):413-423. (Pubitemid 24081781)
36. Juniper EF, Howland WC, Roberts NB, Thompson AK, King DR. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol. 1998;101(2, pt 1):163-170. (Pubitemid 28152377)
37. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy. 2000;30(1):132-140. (Pubitemid 30093890)
38. Craig TJ, Hanks CD, Fisher LH. How do topical nasal corticosteroids improve sleep and daytime somnolence in allergic rhinitis? J Allergy Clin Immunol. 2005;116(6):1264-1266. (Pubitemid 41740933)
39. Yawn BP, Yunginger JW, Wollan PC, Reed CE, Silverstein MD, Harris AG. Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges. J Allergy Clin Immunol. 1999;103(1, pt 1):54-59. (Pubitemid 29063191)
40. Grupp-Phelan J, Lozano P, Fishman P. Health care utilization and cost in children with asthma and selected comorbidities. J Asthma. 2001;38(4):363-373. (Pubitemid 32643145)
41. Stempel DA, Stanford RH, Carranza Rosenzweig JR, McLaughlin TP. The use of rhinitis medications in children receiving initial controller therapy for asthma. Curr Med Res Opin. 2006;22(11):2279-2285. (Pubitemid 44789991)
42. Thomas M, Kocevar VS, Zhang Q, Yin DD, Price D. Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis. Pediatrics. 2005;115(1):129-134. (Pubitemid 43046291)
43. Halpern MT, Schmier JK, Richner R, Guo C, Togias A. Allergic rhinitis: a potential cause of increased asthma medication use, costs, and morbidity. J Asthma. 2004;41(1):117-126. (Pubitemid 38366881)
44. Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol. 2002;109(1):57-62. (Pubitemid 34112130)
45. Adams RJ, Fuhlbrigge AL, Finkelstein JA, Weiss ST. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol. 2002;109(4):636-642. (Pubitemid 34327190)
46. Corren J, Manning BE, Thompson SF, Hennessy S, Strom BL. Rhinitis therapy and the prevention of hospital care for asthma: a case-control study. J Allergy Clin Immunol. 2004;113(3):415-419. (Pubitemid 38338943)
47. Camargos P, Ibiapina C, Lasmar L, Cruz AA. Obtaining concomitant control of allergic rhinitis and asthma with a nasally inhaled corticosteroid. Allergy. 2007;62(3):310-316.
48. Pedersen W, Hjuler I, Bisgaard H, Mygind N. Nasal inhalation of budesonide from a spacer in children with perennial rhinitis and asthma. Allergy. 1998;53(4):383-387. (Pubitemid 28168199)
49. Luskin AT, Blaiss MS, Farrar JR, et al. Is there a role for aerosol nasal sprays in the treatment of allergic rhinitis? a white paper. Allergy Asthma Proc. 2011;32(2):168-177.
50. Marcus CL. Sleep-disordered breathing in children. Am J Respir Crit Care Med. 2001;164(1):16-30. (Pubitemid 33151293)
51. Boruck K, Freeman K, Chervin RD, Xu L. Sleep-disordered breathing in a populationbased cohort: behavioral outcomes at 4 and 7 years. Pediatrics. 2012;129(4):e857-e865.
52. Urschitz MS, Guenther A, Eggebrecht E, et al. Snoring, intermittent hypoxia and academic performance in primary school children. Am J Respir Crit Care Med. 2003;168(4):464-468. (Pubitemid 37046876)
53. Yuksel H, Sogut A, Yilmaz H, Yilmaz O, Dinc G. Sleep actigraphy evidence of improved sleep after treatment of allergic rhinitis. Ann Allergy Asthma Immunol. 2009;103(4):290-294.
54. Kuhle S, Urschitz MS. Anti-inflammatory medications for obstructive sleep apnea in children. Cochrane Database Syst Rev. 2011; (1): CD007074. doi:10.1002/14651858.
55. Griffin G, Flynn CA. Antihistamines and/or decongestants for otitis media with effusion (OME) in children. Cochrane Database Syst Rev. 2011;9:CD003423. doi: 10.1002/14651858. CD003423.pub3.
56. Simpson SA, Lewis R, van der Voort J, Butler CC. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev. 2011;5:CD001935. doi:10.1002/14651858. CD001935.pub3.
57. Parikh A, Alles R, Hawk L, Pringle M, Darby Y, Scadding G. Treatment of allergic rhinitis and its impact in children with chronic otitis media with effusion. J Audiolog Med. 2000;9(2):104-117.
58. Johnstone DE, Dutton A. The value of hyposensitization therapy for bronchial asthma in children: a 14-year study. Pediatrics. 1968;42(5):793-802.
59. Hedlin G, Heilborn H, Lilja G, et al. Long-term follow-up of patients treated with a three-year course of cat or dog immunotherapy. J Allergy Clin Immunol. 1995;96(6, pt 1):879-885.
60. Möller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT study). J Allergy Clin Immunol. 2002;109(2):251-256. (Pubitemid 34158289)
61. Novembre E, Galli E, Landi F, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2004;114(4):851-857. (Pubitemid 39330257)
62. Diepgen TL; Early Treatment of the Atopic Child Study Group. Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, doubleblind, randomized, placebo-controlled trial (the ETAC trial) over 18 months. Pediatr Allergy Immunol. 2002;13(4):278-286. (Pubitemid 35231044)